These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1698158)

  • 1. Morphometric evaluation of benign prostatic hyperplasia.
    Siegel YI; Zaidel L; Hammel I; Korczak D; Lindner A
    Eur Urol; 1990; 18(1):71-3. PubMed ID: 1698158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens.
    Robert M; Costa P; Bressolle F; Mottet N; Navratil H
    Br J Urol; 1995 Mar; 75(3):317-24. PubMed ID: 7537601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology of benign prostatic hyperplasia after failure of hyperthermia treatment.
    Siegel YI; Zaidel L; Hammel I; Korczak D; Lindner A
    Br J Urol; 1991 Oct; 68(4):383-6. PubMed ID: 1718527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
    Bartsch G; Frick J; Rüegg I; Bucher M; Holliger O; Oberholzer M; Rohr HP
    J Urol; 1979 Oct; 122(4):481-6. PubMed ID: 90176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.
    Ishigooka M; Hashimoto T; Hayami S; Suzuki Y; Sasagawa I; Nakada T
    Prostate; 1996 Jun; 28(6):385-91. PubMed ID: 8650076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
    Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
    Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between the quantitative morphometry and the clinical response to alpha adrenergic blocker in benign prostatic hyperplasia].
    Sakai S; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):695-701. PubMed ID: 8709447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes of histological composition in established benign prostatic hyperplasia.
    Ishigooka M; Hayami S; Suzuki Y; Hashimoto T; Sasagawa I; Nakada T
    Eur Urol; 1996; 29(1):85-9. PubMed ID: 8821697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings.
    Ishigooka M; Hayami S; Hashimoto T; Suzuki Y; Katoh T; Nakada T
    Prostate; 1996 Aug; 29(2):77-82. PubMed ID: 8700803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study.
    Tang J; Yang JC; Zhang Y; Liu X; Zhang L; Wang Z; Li J; Luo Y; Xu J; Shi H
    BJU Int; 2007 Nov; 100(5):1091-6. PubMed ID: 17922787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic histology in secondary transurethral resection of the prostate.
    Jønler M; Bruskewitz RC
    J Urol; 1995 Jul; 154(1):119-22. PubMed ID: 7539855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic and histological correlates of benign prostatic hyperplasia.
    Dørflinger T; England DM; Madsen PO; Bruskewitz RC
    J Urol; 1988 Dec; 140(6):1487-90. PubMed ID: 2461453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
    J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of prostatic measuring by transrectal ultrasound in surgical management of patients with clinically benign prostatic hyperplasia.
    Milonas D; Trumbeckas D; Juska P
    Medicina (Kaunas); 2003; 39(9):860-6. PubMed ID: 14515048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight, stroma to gland ratio, and mitotic activity of the human hyperplastic prostate.
    Pietilä J; Arvola I; Senius KE; Tuohimaa P
    Invest Urol; 1977 Jul; 15(1):90-2. PubMed ID: 68946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.
    Bartsch G; Müller HR; Oberholzer M; Rohr HP
    J Urol; 1979 Oct; 122(4):487-91. PubMed ID: 90177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
    Eri LM; Svindland A
    Urology; 2000 Aug; 56(2):261-5. PubMed ID: 10925090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
    Matsuda T; Fujime M; Suda K
    Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of percent area density of epithelial and stromal components in development of prostatic hyperplasia in spontaneously hypertensive rats.
    Yamashita M; Zhang X; Shiraishi T; Uetsuki H; Kakehi Y
    Urology; 2003 Feb; 61(2):484-9. PubMed ID: 12597986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of benign prostatic hyperplasia. Insight into etiology.
    McNeal J
    Urol Clin North Am; 1990 Aug; 17(3):477-86. PubMed ID: 1695776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.